We narrowed to 5,349 results for: yfp

1. AiP15041 - pAAV-AiE1417m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN5041)

   Plasmid

   #224187

   Purpose

   AiE1417m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal Pvalb+/Pthlh+ neurons

   Depositor

   Jonathan Ting, Allen Institute for Brain Science

   Article

   Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

   Insert

   SYFP2-P2A-3XFLAG-10aa-H2B
   

   Use

   AAV

   Available Since

   Sept. 25, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pcDNA3.1 Flag YFP hNKCC1 P676C I730C N-terminal deletion C-terminus replaced NBCe C-terminus (NT94)

   Plasmid

   #50912

   Purpose

   Expresses human NKCC1 with truncation of N-terminus, mutations at P676C I730C and C-terminus replaced with that of NBCe. Contains an N-terminal 3xFLAG-YFP tag for expression in mammalian cells

   Depositor

   Biff Forbush

   Article

   Monette et al J Biol Chem. 2014 Jan 22.

   Insert

   human NKCC1 (synthetic) (SLC12A2 Human, Synthetic)
   

   Tags

   3x Flag and YFP

   Expression

   Mammalian

   Mutation

   P676C and I730C; N-term deletion of aa13-222; C-t…

   Promoter

   CMV

   Available Since

   Feb. 24, 2014

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. pAAV-hSyn1-eYFP (AAV2)

   Viral Prep

   #117382-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Feb. 14, 2022

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CAG-eYFP (AAV2)

   Viral Prep

   #104055-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   CAG

   Tags

   EYFP

   Available Since

   June 13, 2023

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-hSyn1-eYFP (AAV5)

   Viral Prep

   #117382-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Oct. 28, 2021

   Availability

   Academic Institutions and Nonprofits only

6. pAAV.CamKII(1.3).eYFP.WPRE.hGH (AAV1)

   Viral Prep

   #105622-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV.CamKII(1.3).eYFP.WPRE.hGH (#105622). In addition to the viral particles, you will also receive purified pAAV.CamKII(1.3).eYFP.WPRE.hGH plasmid DNA. Expression of EYFP from CaMKII(1.3) promoter. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   CaMKII(1.3)

   Tags

   EYFP

   Available Since

   July 30, 2018

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-hSyn1-eYFP (AAV9)

   Viral Prep

   #117382-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-hSyn1-eYFP (AAV8)

   Viral Prep

   #117382-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-hSyn1-eYFP (AAV1)

   Viral Prep

   #117382-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Aug. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CAG-eYFP (AAV5)

    Viral Prep

    #104055-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    CAG

    Tags

    EYFP

    Available Since

    Sept. 27, 2023

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-hSyn1-eYFP (AAV Retrograde)

    Viral Prep

    #117382-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    Syn

    Tags

    eYFP

    Available Since

    Oct. 18, 2021

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hSyn1-eYFP (AAV PHP.eB)

    Viral Prep

    #117382-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    Syn

    Tags

    eYFP

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-CAG-eYFP (AAV Retrograde)

    Viral Prep

    #104055-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    CAG

    Tags

    EYFP

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-CAG-eYFP (AAV PHP.eB)

    Viral Prep

    #104055-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    CAG

    Tags

    EYFP

    Available Since

    June 13, 2023

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-Ef1a-fDIO EYFP (AAV1)

    Viral Prep

    #55641-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO EYFP (#55641). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO EYFP plasmid DNA. EF1a-driven, Flp-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    EF1a

    Tags

    EYFP (Flp-dependent)

    Available Since

    Aug. 28, 2020

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-Ef1a-fDIO EYFP (AAV8)

    Viral Prep

    #55641-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Ef1a-fDIO EYFP (#55641). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO EYFP plasmid DNA. EF1a-driven, Flp-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    EF1a

    Available Since

    Dec. 18, 2024

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-Ef1a-DIO EYFP (AAV5)

    Viral Prep

    #27056-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Tags

    EYFP (Cre-dependent)

    Available Since

    Feb. 14, 2018

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-Ef1a-DIO EYFP (AAV1)

    Viral Prep

    #27056-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Tags

    EYFP (Cre-dependent)

    Available Since

    March 16, 2018

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-S5E2-C1V1-eYFP (AAV1)

    Viral Prep

    #135633-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    EYFP

    Available Since

    Aug. 27, 2021

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-TRE-DIO-eYFP (AAV1)

    Viral Prep

    #117383-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-TRE-DIO-eYFP (#117383). In addition to the viral particles, you will also receive purified pAAV-TRE-DIO-eYFP plasmid DNA. Tet-inducible, Cre-dependent eYFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    TRE

    Tags

    eYFP (Tet-inducible, Cre-dependent)

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only